GTF2IRD1
Reaktivität: Human
Wirt: Synthetic
BP, BI
Applikationshinweise
Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Buffer
Lyophilized powder
Lagerung
-20 °C
Informationen zur Lagerung
Shipped at 4°C. Store at -20°C for one year.
Haltbarkeit
12 months
Target
GTF2IRD1
(General Transcription Factor II I Repeat Domain-Containing 1 (GTF2IRD1))
CREAM1, GTF3, MUSTRD1, RBAP2, WBSCR11, WBSCR12, General transcription factor II-I repeat domain-containing protein 1, GTF2I repeat domain-containing protein 1, General transcription factor III, MusTRD1/BEN, Muscle TFII-I repeat domain-containing protein 1, Slow-muscle-fiber enhancer-binding protein, USE B1-binding protein, Williams-Beuren syndrome chromosomal region 11 protein, Williams-Beuren syndrome chromosomal region 12 protein